GnRH blockers: a changing paradigm in the management of prostate cancer

被引:6
|
作者
Drudge-Coates, Lawrence [1 ]
机构
[1] Kings Coll Hosp London, Dept Urol, London SE5 9RS, England
关键词
Androgen deprivation; Degarelix; Gonadotrophin-receptor blocker; Hormonal therapy; Prostate cancer; ANDROGEN DEPRIVATION THERAPY; OPEN-LABEL; HORMONE; CASTRATION; DEGARELIX; TESTOSTERONE; ANTAGONISTS; CARCINOMA; EFFICACY; SAFETY;
D O I
10.1111/j.1749-771X.2009.01081.x
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The development of GnRH blockers provides a new class of hormonal agent with a different, direct mode of action. Degarelix, a newly approved GnRH blocker, has displayed a fast, profound and sustained suppression of testosterone and prostate-specific antigen levels without subsequent tumour flare effects. This paper considers the current evidence for this new treatment approach and how this may impact on current urology nursing practice.
引用
收藏
页码:85 / 92
页数:8
相关论文
共 50 条
  • [31] Is Prostate Cancer Changing?
    Doctor, Stephanie M.
    Tsao, Che-Kai
    Godbold, James H.
    Galsky, Matthew D.
    Oh, William K.
    CANCER, 2014, 120 (06) : 833 - 839
  • [32] Active surveillance: towards a new paradigm in the management of early prostate cancer
    Parker, C
    LANCET ONCOLOGY, 2004, 5 (02): : 101 - 106
  • [33] Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells
    J. Y. Bahk
    J. S. Hyun
    B.H. Lee
    M. O. Kim
    G. J. Cho
    W. S. Choi
    Urological Research, 1998, 26 : 259 - 264
  • [34] Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells
    Bahk, JY
    Hyun, JS
    Lee, H
    Kim, MO
    Cho, GJ
    Lee, BH
    Choi, WS
    UROLOGICAL RESEARCH, 1998, 26 (04): : 259 - 264
  • [35] Calcium channel blockers and prostate cancer
    Loughlin, Kevin R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (05) : 537 - 538
  • [36] Prostate cancer: the bone paradigm ...
    Tombal, B.
    EJC SUPPLEMENTS, 2009, 7 (02): : 16 - 16
  • [37] Prostate Cancer: An Evolving Paradigm
    Caso, Jorge R.
    Mouraviev, Vladimir
    Tsivian, Matvey
    Polascik, Thomas J.
    Moul, Judd W.
    JOURNAL OF ENDOUROLOGY, 2010, 24 (05) : 805 - 809
  • [38] Prostate cancer vaccine: A new paradigm for prostate cancer treatment
    Dwivedi, Amod Kumar
    Sengottayan, Vengetesh K.
    Goel, Apul
    INDIAN JOURNAL OF UROLOGY, 2011, 27 (01) : 148 - 149
  • [39] Changing the Paradigm of Cancer Control in Cuba
    Romero, Teresa
    MEDICC REVIEW, 2009, 11 (03) : 5 - 7
  • [40] Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics
    A Paschos
    R Pandya
    W C M Duivenvoorden
    J H Pinthus
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 217 - 225